“We will assess how the commercialization of substances fits with our business model at Adastra, in an effort to position ourselves to support the demand for a safe supply of cocaine”, stated the CEO of the Canadian company Adastra Labs, Michael Forbes.
the pharmaceutical laboratory Adastra Labs, Until now dedicated to the production of cannabis extracts, it received a license last February for the production of substances considered “hard drugs”, according to the AFP news agency. Adastra’s license also allows it to produce and sell psilocybin and psilocin, hallucinogenic better known as “fungus” They produce effects similar to LSD.
On Thursday, March 2, another company also obtained a license to produce and sell cocaine, and other drugs with similar addictive characteristics. This approval comes shortly after the government decriminalized the possession of small amounts of this class of substances, the international press reported.
the pharmaceutical firm Sunshine Earth Lab said in a statement that it received permission from the Health Canada to “lawfully possess, produce, sell, and distribute coca leaf and cocaine,” as well as morphine, ecstasy and heroin. A policy of opening, in the governmental operation, on the problem of addictions and drug use.
The Canadian national government granted, in mid-January of this year, an exemption from the Penal Code to the province british columbia to develop a three-year pilot project there to remove the stigma associated with drug use that prevents people from seeking help. A sensitive record that is verified in the statistics of local health agencies.
british columbia It is the second North American jurisdiction to decriminalize hard drugs, after the US state Oregon did so in November 2020. According to official statistics, the Canadian province recorded more than 10,000 overdose deaths since 2016, at an average of six per day in a population of five million people.
TELAM Source
Image gallery
